Torrent Pharmaceuticals Statistics

Total Valuation

NSE:TORNTPHARM has a market cap or net worth of INR 1.07 trillion. The enterprise value is 1.10 trillion.

Market Cap	1.07T
Enterprise Value	1.10T

Important Dates

The next estimated earnings date is Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	Jun 20, 2025

Share Statistics

Current Share Class	338.45M
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	105.92M

Valuation Ratios

The trailing PE ratio is 56.12 and the forward PE ratio is 42.91.

PE Ratio	56.12
Forward PE	42.91
PS Ratio	9.31
PB Ratio	14.13
P/TBV Ratio	35.88
P/FCF Ratio	54.33
P/OCF Ratio	41.49
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.50, with an EV/FCF ratio of 55.60.

EV / Earnings	57.44
EV / Sales	9.53
EV / EBITDA	29.50
EV / EBIT	37.51
EV / FCF	55.60

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.42.

Current Ratio	1.19
Quick Ratio	0.54
Debt / Equity	0.42
Debt / EBITDA	0.86
Debt / FCF	1.62
Interest Coverage	11.61

Financial Efficiency

Return on equity (ROE) is 26.46% and return on invested capital (ROIC) is 16.86%.

Return on Equity (ROE)	26.46%
Return on Assets (ROA)	12.17%
Return on Invested Capital (ROIC)	16.86%
Return on Capital Employed (ROCE)	28.48%
Revenue Per Employee	7.33M
Profits Per Employee	1.22M
Employee Count	15,718
Asset Turnover	0.77
Inventory Turnover	1.15

Taxes

In the past 12 months, NSE:TORNTPHARM has paid 7.62 billion in taxes.

Income Tax	7.62B
Effective Tax Rate	28.51%

Stock Price Statistics

The stock price has increased by +11.59% in the last 52 weeks. The beta is 0.16, so NSE:TORNTPHARM's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+11.59%
50-Day Moving Average	3,223.19
200-Day Moving Average	3,260.05
Relative Strength Index (RSI)	43.28
Average Volume (20 Days)	334,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:TORNTPHARM had revenue of INR 115.16 billion and earned 19.11 billion in profits. Earnings per share was 56.47.

Revenue	115.16B
Gross Profit	87.40B
Operating Income	29.26B
Pretax Income	26.73B
Net Income	19.11B
EBITDA	37.21B
EBIT	29.26B
Earnings Per Share (EPS)	56.47

Full Income Statement

Balance Sheet

The company has 6.91 billion in cash and 32.02 billion in debt, giving a net cash position of -25.11 billion.

Cash & Cash Equivalents	6.91B
Total Debt	32.02B
Net Cash	-25.11B
Net Cash Per Share	n/a
Equity (Book Value)	75.91B
Book Value Per Share	224.22
Working Capital	9.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.85 billion and capital expenditures -6.11 billion, giving a free cash flow of 19.74 billion.

Operating Cash Flow	25.85B
Capital Expenditures	-6.11B
Free Cash Flow	19.74B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.89%, with operating and profit margins of 25.41% and 16.59%.

Gross Margin	75.89%
Operating Margin	25.41%
Pretax Margin	23.21%
Profit Margin	16.59%
EBITDA Margin	32.31%
EBIT Margin	25.41%
FCF Margin	17.14%

Dividends & Yields

This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 1.01%.

Dividend Per Share	32.00
Dividend Yield	1.01%
Dividend Growth (YoY)	14.29%
Years of Dividend Growth	1
Payout Ratio	56.67%
Buyback Yield	0.01%
Shareholder Yield	1.02%
Earnings Yield	1.78%
FCF Yield	1.84%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jul 8, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	8